Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending May 26, 2006. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding Ordinary Shares of the Company.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory notification of share transactions and does not contain financial performance data.
Material Changes
The filing details specific share transfers from the GlaxoSmithKline Employee Trust ("the GSK Trust") to participants in the SmithKline Beecham Employee Share Option Plan 1991:
- May 24, 2006: Transfer of 20,378 Ordinary Shares.
- May 25, 2006: Transfer of 10,014 Ordinary Shares.
These transactions were advised to the Company on May 26, 2006.
Management Commentary and Risks
The GSK Trust is identified as a discretionary trust where all current and former employees of GlaxoSmithKline plc and its subsidiaries are potential beneficiaries. The filing notes that three directors (Dr J-P Garnier, Dr T Yamada, and Mr J S Heslop) hold interests in the shares held by the GSK Trust in the same capacity as other employees. No other risks, contingencies, or unusual items are disclosed in this text.
Investor Verification Points
- Verify the total number of shares transferred under the SmithKline Beecham Employee Share Option Plan 1991 during the reporting period.
- Confirm the specific interests of Directors Dr J-P Garnier, Dr T Yamada, and Mr J S Heslop in the GSK Trust.
- Note that this filing does not contain financial results; refer to Form 20-F for comprehensive financial data.